Skip to main content
Clinical Trials/ISRCTN32956054
ISRCTN32956054Completed未知

Assessment of cost-effectiveness of the treatment of varicose veins

Department of Health (UK)0 sites1,009 target enrollmentStarted: April 25, 2003Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
1,009

Study Overview

Brief Summary

2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16707070 HTA monograph

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients undergoing treatment for varicose veins

Exclusion Criteria

  • Added as of 25/07/2007:
  • General exclusion criteria:
  • 1. Unwillingness to give informed consent
  • 2. Unwilling or unable to complete assessment protocol
  • 3. Current evidence of thrombophlebitis, ulceration or DVT
  • Specific exclusion criteria:
  • Group 1 Sclerotherapy vs conservative treatment:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • Group 2 Sclerotherapy vs surgery:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • 4. Pre-existing co-morbidities that would make them unsuitable for surgery
  • 5. BMI >32
  • Group 3 Surgery vs conservative treatment:
  • 1. Patients with deep venous insufficiency confirmed by duplex
  • 2. Allergy to sclerosant
  • 3. Diameter of varicose veins >2 cm
  • 4. Pre-existing co-morbidities that would make them unsuitable for surgery.
  • 5. BMI >32

Investigators

Sponsor
Department of Health (UK)

Similar Trials